These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27682244)

  • 1. Regulation of aPKC activity by Nup358 dependent SUMO modification.
    Yadav SK; Magre I; Singh A; Khuperkar D; Joseph J
    Sci Rep; 2016 Sep; 6():34100. PubMed ID: 27682244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nup358 regulates microridge length by controlling SUMOylation-dependent activity of aPKC in zebrafish epidermis.
    Magre I; Fandade V; Damle I; Banerjee P; Yadav SK; Sonawane M; Joseph J
    J Cell Sci; 2019 Jun; 132(12):. PubMed ID: 31164446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nup358 interacts with Dishevelled and aPKC to regulate neuronal polarity.
    Vyas P; Singh A; Murawala P; Joseph J
    Biol Open; 2013; 2(11):1270-8. PubMed ID: 24244865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
    Werner A; Flotho A; Melchior F
    Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer.
    Nolan ME; Aranda V; Lee S; Lakshmi B; Basu S; Allred DC; Muthuswamy SK
    Cancer Res; 2008 Oct; 68(20):8201-9. PubMed ID: 18922891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1.
    Lin CH; Liu SY; Lee EH
    Oncogene; 2016 Feb; 35(5):595-607. PubMed ID: 25867063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells.
    Mao M; Fang X; Lu Y; Lapushin R; Bast RC; Mills GB
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):475-82. PubMed ID: 11085941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p32 is a novel mammalian Lgl binding protein that enhances the activity of protein kinase Czeta and regulates cell polarity.
    Bialucha CU; Ferber EC; Pichaud F; Peak-Chew SY; Fujita Y
    J Cell Biol; 2007 Aug; 178(4):575-81. PubMed ID: 17682048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarity proteins PAR6 and aPKC regulate cell death through GSK-3beta in 3D epithelial morphogenesis.
    Kim M; Datta A; Brakeman P; Yu W; Mostov KE
    J Cell Sci; 2007 Jul; 120(Pt 14):2309-17. PubMed ID: 17606986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdc42, Par6, and aPKC regulate Arp2/3-mediated endocytosis to control local adherens junction stability.
    Georgiou M; Marinari E; Burden J; Baum B
    Curr Biol; 2008 Nov; 18(21):1631-8. PubMed ID: 18976918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenovirus E4-ORF3 protein functions as a SUMO E3 ligase for TIF-1γ sumoylation and poly-SUMO chain elongation.
    Sohn SY; Hearing P
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6725-30. PubMed ID: 27247387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Protein Kinase C Promotes its own Asymmetric Localisation by Phosphorylating Cdc42 in the
    Packer J; Gubieda AG; Brooks A; Deutz LN; Squires I; Ellison S; Schneider C; Naganathan SR; Wollman AJM; Dickinson DJ; Rodriguez J
    bioRxiv; 2024 Jun; ():. PubMed ID: 38009101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly.
    Swaminathan S; Kiendl F; Körner R; Lupetti R; Hengst L; Melchior F
    J Cell Biol; 2004 Mar; 164(7):965-71. PubMed ID: 15037602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
    Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
    Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partitioning-defective protein 6 regulates insulin-dependent glycogen synthesis via atypical protein kinase C.
    Weyrich P; Kapp K; Niederfellner G; Melzer M; Lehmann R; Häring HU; Lammers R
    Mol Endocrinol; 2004 May; 18(5):1287-300. PubMed ID: 14976222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
    Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro Reconstitution of a Membrane Switch Mechanism for the Polarity Protein LGL.
    Visco I; Hoege C; Hyman AA; Schwille P
    J Mol Biol; 2016 Dec; 428(24 Pt A):4828-4842. PubMed ID: 27720986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective activation of atypical protein kinase C zeta and lambda by insulin and phosphatidylinositol-3,4,5-(PO4)(3) in skeletal muscle of rats following high-fat feeding and streptozotocin-induced diabetes.
    Kanoh Y; Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Farese RV
    Endocrinology; 2003 Mar; 144(3):947-54. PubMed ID: 12586772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of Tbx5-mediated transactivation by SUMO conjugation and protein inhibitor of activated STAT 1 (PIAS1).
    Beketaev I; Kim EY; Zhang Y; Yu W; Qian L; Wang J
    Int J Biochem Cell Biol; 2014 May; 50():82-92. PubMed ID: 24582888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.